vs
Side-by-side financial comparison of Currenc Group Inc. (CURR) and EyePoint, Inc. (EYPT). Click either name above to swap in a different company.
Currenc Group Inc. is the larger business by last-quarter revenue ($10.1M vs $5.3M, roughly 1.9× EyePoint, Inc.). Currenc Group Inc. runs the higher net margin — -46.5% vs -1114.3%, a 1067.8% gap on every dollar of revenue. On growth, Currenc Group Inc. posted the faster year-over-year revenue change (-23.3% vs -43.7%). Currenc Group Inc. produced more free cash flow last quarter ($-1.7M vs $-63.8M).
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
CURR vs EYPT — Head-to-Head
Income Statement — Q1 FY2025 vs Q2 FY2025
| Metric | ||
|---|---|---|
| Revenue | $10.1M | $5.3M |
| Net Profit | $-4.7M | $-59.4M |
| Gross Margin | 31.8% | — |
| Operating Margin | -43.0% | -1166.8% |
| Net Margin | -46.5% | -1114.3% |
| Revenue YoY | -23.3% | -43.7% |
| Net Profit YoY | -54.0% | -92.8% |
| EPS (diluted) | $-0.13 | $-0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | — | $5.3M | ||
| Q1 25 | $10.1M | $24.5M | ||
| Q4 24 | — | $11.6M | ||
| Q3 24 | $11.3M | $10.5M | ||
| Q2 24 | — | $9.5M | ||
| Q1 24 | $13.1M | $11.7M | ||
| Q4 23 | — | $14.0M | ||
| Q3 23 | $12.7M | $15.2M |
| Q2 25 | — | $-59.4M | ||
| Q1 25 | $-4.7M | $-45.2M | ||
| Q4 24 | — | $-41.4M | ||
| Q3 24 | $-5.0M | $-29.4M | ||
| Q2 24 | — | $-30.8M | ||
| Q1 24 | $-3.0M | $-29.3M | ||
| Q4 23 | — | $-14.1M | ||
| Q3 23 | $-3.8M | $-12.6M |
| Q2 25 | — | — | ||
| Q1 25 | 31.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 27.8% | 93.0% | ||
| Q2 24 | — | 85.2% | ||
| Q1 24 | 33.6% | 93.5% | ||
| Q4 23 | — | — | ||
| Q3 23 | 32.5% | 92.1% |
| Q2 25 | — | -1166.8% | ||
| Q1 25 | -43.0% | -199.7% | ||
| Q4 24 | — | -390.4% | ||
| Q3 24 | -141.5% | -311.2% | ||
| Q2 24 | — | -364.5% | ||
| Q1 24 | -10.8% | -285.2% | ||
| Q4 23 | — | -116.6% | ||
| Q3 23 | -18.2% | -94.7% |
| Q2 25 | — | -1114.3% | ||
| Q1 25 | -46.5% | -184.8% | ||
| Q4 24 | — | -357.3% | ||
| Q3 24 | -44.1% | -279.0% | ||
| Q2 24 | — | -325.3% | ||
| Q1 24 | -23.2% | -250.6% | ||
| Q4 23 | — | -100.5% | ||
| Q3 23 | -30.1% | -83.0% |
| Q2 25 | — | $-0.85 | ||
| Q1 25 | $-0.13 | $-0.65 | ||
| Q4 24 | — | $-0.65 | ||
| Q3 24 | $-0.13 | $-0.54 | ||
| Q2 24 | — | $-0.58 | ||
| Q1 24 | $-0.09 | $-0.55 | ||
| Q4 23 | — | $-0.32 | ||
| Q3 23 | $-0.11 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $62.3M | $255.7M |
| Total DebtLower is stronger | $3.7M | — |
| Stockholders' EquityBook value | $-68.4M | $246.0M |
| Total Assets | $110.8M | $301.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $255.7M | ||
| Q1 25 | $62.3M | $318.2M | ||
| Q4 24 | — | $370.9M | ||
| Q3 24 | $49.1M | $253.8M | ||
| Q2 24 | — | $280.2M | ||
| Q1 24 | — | $299.3M | ||
| Q4 23 | — | $331.1M | ||
| Q3 23 | — | $136.0M |
| Q2 25 | — | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q2 25 | — | $246.0M | ||
| Q1 25 | $-68.4M | $298.4M | ||
| Q4 24 | — | $336.5M | ||
| Q3 24 | $-47.0M | $218.7M | ||
| Q2 24 | — | $228.3M | ||
| Q1 24 | $-10.9M | $249.9M | ||
| Q4 23 | — | $266.3M | ||
| Q3 23 | $-10.2M | $58.6M |
| Q2 25 | — | $301.1M | ||
| Q1 25 | $110.8M | $362.6M | ||
| Q4 24 | — | $418.5M | ||
| Q3 24 | $115.0M | $300.9M | ||
| Q2 24 | — | $324.2M | ||
| Q1 24 | $54.5M | $329.2M | ||
| Q4 23 | — | $355.2M | ||
| Q3 23 | $82.0M | $160.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-1.5M | $-62.6M |
| Free Cash FlowOCF − Capex | $-1.7M | $-63.8M |
| FCF MarginFCF / Revenue | -16.5% | -1196.5% |
| Capex IntensityCapex / Revenue | 1.7% | 22.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-194.0M |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $-62.6M | ||
| Q1 25 | $-1.5M | $-53.1M | ||
| Q4 24 | — | $-35.8M | ||
| Q3 24 | $-11.3M | $-39.0M | ||
| Q2 24 | — | $-20.2M | ||
| Q1 24 | $-221.0K | $-31.2M | ||
| Q4 23 | — | $-23.1M | ||
| Q3 23 | $-10.5M | $-15.2M |
| Q2 25 | — | $-63.8M | ||
| Q1 25 | $-1.7M | $-53.4M | ||
| Q4 24 | — | $-36.2M | ||
| Q3 24 | — | $-40.6M | ||
| Q2 24 | — | $-21.1M | ||
| Q1 24 | $-233.0K | $-32.4M | ||
| Q4 23 | — | $-24.0M | ||
| Q3 23 | — | $-16.9M |
| Q2 25 | — | -1196.5% | ||
| Q1 25 | -16.5% | -218.4% | ||
| Q4 24 | — | -312.7% | ||
| Q3 24 | — | -385.8% | ||
| Q2 24 | — | -222.4% | ||
| Q1 24 | -1.8% | -277.0% | ||
| Q4 23 | — | -171.0% | ||
| Q3 23 | — | -111.3% |
| Q2 25 | — | 22.9% | ||
| Q1 25 | 1.7% | 1.1% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 15.0% | ||
| Q2 24 | — | 9.5% | ||
| Q1 24 | 0.1% | 10.2% | ||
| Q4 23 | — | 6.3% | ||
| Q3 23 | — | 11.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CURR
| Sales Of Airtime | $5.5M | 54% |
| Fiat Remittance Service | $4.4M | 44% |
EYPT
Segment breakdown not available.